Abstract
Ochratoxin A (OTA) has been detected in high amounts in human blood samples collected in nephrology departments in Tunisia from nephropathy patients under dialysis, especially those categorised as having a chronic interstitial nephropathy of unknown aetiology. These represent 12–26.1% of all chronic renal failure patients. To clarify the situation, food and blood samples were collected from nephropathy patients and controls, (with no familial case of nephropathy). The OTA assay showed very different scales of OTA food and blood contamination from 0.1 to 16.6 μg/kg and 0.1–2.3 ng/ml, respectively, in controls and healthy individuals and 0.3–46 830 μg/kg for food and 0.7–1136 ng/ml for blood in nephropathy patients. The disease seems related to OTA blood levels and food contaminations, since the control group was significantly different from the nephropathy group (p<0.005) for both food and blood ochratoxin A contamination. Combined with data published already, the results emphasize the likely endemic aspect of this OTA-related nephropathy occurring in Tunisia and possibly in other countries of northern Africa. This nephropathy is very similar to Balkan endemic nephropathy.
Similar content being viewed by others
References
Achour A, El-May M, Bacha H, Hammami M, Maaroufi K, Creppy EE (1993) Néphropathies interstitielles chroniques. Approches cliniques et étiologiques: ochratoxine A. In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies, vol 231, Colloque INSERM/John Libbey Eurotext, pp 227–234
Arora RG, Frölen H (1981) Interference of mycotoxins with prenatal development of the mouse. II. Ochratoxin A induced teratogenic effects in relation to the dose and stage of gestation. Acta, Vet, Scand, 22: 535–552
Bacha H, Hadidane R, Regnault CR, Ellouz F, Creppy EE, Dirheimer G (1986) Mycotoxines et Mycotoxicoses en Tunisie. Cahiers Médicaux de Tunisie—Nutrition et Santé, vol 49: 34–35
Bacha H, Hadidane R, Regnault CR, Ellouz F, Creppy EE, Dirheimer G (1988) Monitoring and identification of fungal toxins in food products, animal feed and cereals in Tunisia. J Stored Prod Res 24: 199–206
Bacha H, Maaroufi K, Achour A; Hammami M, Ellouz F, Creppy EE (1993) Ochratoxines et ochratoxicoses humaines en Tunisie. In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies, vol 231. Colloque INSERM/John Libbey Eurotext, pp 111–121
Bauer J, Gareis M (1987) Ochratoxin A in der Nahrungsmittelkette. Z Vet B 34: 613–627
Bendele AM, Carlton WW, Krogh P, Lillehoj EB (1985) Ochratoxin A carcinogenesis in the (C 57BL/6J×C3H) F1 mouse. J Natl Cancer Inst 75: 733–742
Breitholtz A, Olsen M, Dahlback A, Hult K (1991) Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam 8: 183–192
Bunge I, Dirheimer G, Röschenthaler R (1978) In vivo and in vitro inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem Biophys Res Commun 83: 398–405
Creppy EE (1992) Human ochratoxicosis in northern Africa, correlation with cases of nephropathy. Report of a network from Tunisia and Algeria. 14 th Mycotoxin Workshop, Giessen, pp 68–69
Creppy EE, Lugnier AAJ, Fasiolo F, Heller K, Röschenthaler R, Dirheimer G (1979a) In vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A. Chem Biol Interact 24: 257–262
Creppy EE, Lugnier AAJ, Beck G, Röschenthaler R, Dirheimer G (1979b) Action of ochratoxin A on cultured hepatoma cells. Reversion of inhibition by phenylalanine. FEBS Lett 104: 287–290
Creppy EE, Lorkowski G, Beck G, Röschenthaler R, Dirheimer G (1980) Combined action of citrinin and ochratoxin A on hepatoma tissue culture cells. Toxicol Lett 5: 375–380
Creppy EE, Kern D, Steyn PS, Vleggaar R, Röschenthaler R, Dirheimer G (1983a) Comparative study of the effect of ochratoxin A analogues on yeast aminoacyl-tRNA synthetase and on growth and protein synthesis in hepatoma cells. Toxicol Lett 19: 217–224
Creppy EE, Stormer FC, Röschenthaler R, Dirheimer G (1983b) Effects of two metabolites of ochratoxin A, (4R)-4-hydroxyochratoxin A and ochratoxin alpha on the immune response in mice. Infect Immun 39: 1015–1018
Creppy EE, Kane A, Dirheimer G, Lafarge-Frayssinet C, Mousset S (1985) Genotoxicity of ochratoxin A in mice: DNA single-strand breacks. Evaluation in spleen liver and kidney. Toxicol Lett 28: 29–35
Creppy EE, Betbeder A-M, Gharbi A, Counord J, Castegnaro M, Bartsch H, Moncharmont P, Fouillet B, Chambon P, Dirheimer G (1991) Human ochratoxicosis in France. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours, vol 115. IARC Scientific Publications, Lyon, pp 145–151
Creppy EE, Castegnaro M, Grosse Y, Meriaux J, Manier C, Moncharmont P, Waller C (1993) Etude de l’ochratoxicose humaine dans trois régions de France: Alsace, Aquitaine et Région Rhône-Alpes. In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies, vol 231 Colloque INSERM/John Libbey Eurotext, pp 147–158
Delacruz L, Bach PH (1990) The role of ochratoxin A metabolism and biochemistry in animal and human nephrotoxicity. J Biopharm Sci 1: 277–304
Dirheimer G, Creppy EE (1991) Mechanism of action of ochratoxin A. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours, vol 115. IARC Scientific Publications, Lyon, pp 171–176
Dwivedi P, Burns RB (1985) Immunosuppressive effect of ochratoxin A in young turkeys. Avian Pathol 14: 213–225
Fink-Gremmels J, Blom M, Woutersen van Nijnanten F (1993) In vitro investigations on ochratoxin A metabolism. In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies, vol 231. Colloque INSERM/John Libbey Eurotext, pp 67–74
Galtier P, Bonen B, Charpenteau JL, Bodin G, Alvinerie M, More J (1979) Physiopathology of haemorrhagic syndrom related to ochratoxin A intoxication in rats. Food Cosmet Toxicol 17: 49–53
Gupta M, Bandyopadhyay S, Paul B, Majumder S (1979) Hematological changes produced in mice by ochratoxin A. Toxicology 14: 95–98
Hadidane R, Roger-Regnault C, Bouatour H, Ellouz F, Bacha H, Creppy EE, Dirheimer G (1985) Correlation between alimentary mycotoxin contamination and specific diseases. Hum Toxicol 4: 491–501
Hadidane R, Bacha H, Creppy EE, Hammami M, Ellouz F, Dirheimer G (1992) Isolation and structure determination of natural analogues of the mycotoxin ochratoxin A produced by Aspergillus ochraceus. Toxicology 76: 233–243
Hagelberg S, Fuchs R, Hult K (1989) Toxicokinetics of ochratoxin A in several species and its plasma binding properties. J Appl Toxicol 9: 91–96
Hald B (1991) Ochratoxin A in human blood in European countries. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, endemic nephropathy and urinary tract tumours, vol 115. IARC Scientific Publications, Lyon, pp 159–164
Haubeck HD, Lorkowski G, Kölsch E, Röschenthaler R (1981) Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl Environ Microbiol 41: 1040–1042
Kane A, Creppy EE, Röschenthaler R, Dirheimer G (1986a) Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology 42: 233–243
Kane A, Creppy EE, Roth A, Röschenthaler R, Dirheimer G (1986b) Distribution of the [3H]-labell from low doses of radioactive ochratoxin A ingested by rats and evidence for DNA single-strand breaks caused in liver and kidneys. Arch Toxicol 58: 219–224
Kanisawa M (1984) Synergistic effect of citrinin on hepatorenal carcinogenesis of ochratoxin A in mice. Dev Food Sci 7: 245–254
Kanisawa M, Suzuki S (1978) Induction of renal and hepatic tumours in mice by ochratoxin A, a mycotoxin. Gann 69: 599–600
Klaassen CD (1986) Distribution, excretion and absorption of toxicants. In: Klaassen, C.D. Amdur, and Doull J. (eds) The basic science of poisons, Casarett and Doulls Toxicology, 3rd edn New-York, MacMillian, pp 33–63
Krogh P (1987) Ochratoxins in food. In: Krogh P (ed) Mycotoxins in food. Academic Press, New-York, pp 97–121
Krogh P, Hald B, Plestina R, Ceovic S (1977) Balkan (endemic) nephropathy and foodborne ochratoxin A: preliminary results of a survey of foodstuffs. Acta Pathol Microbiol Scand Sect B 85: 238–240
Kuiper-Goodman T, Scott PM (1989) Risk assessment of the mycotoxin ochratoxin A. Biomed Environ Sci 2: 179–248
Maaroufi K, Achour A, Hammami M, El-May M, Betbeder A-M, Ellouz F, Creppy EE, Bacha H (1995) Ochratoxins in human blood and nephropathy in Tunisia. Hum Exp Toxicol (in press)
Mayura K, Parker R, Berndt WO, Phillips TD (1984) Ochratoxin A induced teratogenesis in rats: partial protection by phenylalanine. Appl Environ Microbiol 48: 1186–1188
NTP (1989) Technical report on the toxicology and carcinogenesis studies of ochratoxin A (Case N° 303-47-9) in F344/N rats (gavage studies), Boorman G (ed) US Department of Health and Human Services, Research Triangle Park, NC, National Institutes of Health, (NIH Publication) N° 89-2813
Petkova-Bocharova T, Chernozemsky IN, Castegnaro M (1988) Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary system tumours in Bulgaria. Food Addit Contam 5: 299–301
Pfohl-Leszkowicz A, Chakor K, Creppy EE, Dirheimer G (1991) DNA-adduct formation in mice treated with ochratoxin A. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin endemic nephropathy and urinary tract tumours, vol 115. IARC Scientific Publications, Lyon, pp 245–253
Pitout MJ (1968) The effect of ochratoxin A on glycogen storage in rat liver. Toxicol Appl Pharmacol 13: 299–306
Pohland AE, Nesheim S, Friedman L (1992) Ochratoxin A: a review. Pure Appl Chem 64: 1029–1046
Sansing GA, Lillehoj RW, Miller MA (1976) Synergistic toxic effects of citrinin, ochratoxin A and penicillic acid in mice. Toxicon 14: 213–220
Speijers GJA, Van Egmond HP (1993) Worldwide ochratoxin A levels in food and feeds In: Creppy EE, Castegnaro M, Dirheimer G (eds) Human ochratoxicosis and its pathologies, vol 231. Colloque INSERM/John Libbey Eurotext ltd, pp 85–100
Stormer FC (1992) Ochratoxin A. A mycotoxin of concern. In: Bhatnagar D, Lillehoj EB Arora DK (eds) Handbook of applied mycology. Dekker, New York, pp 403–432
Stormer FC, Storen O, Hansen CH, Pedersen JI, Aasen AJ (1983) Formation of [4R]-and [4S]-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from ochratoxin A by rabbit liver microsomes. Appl Environ Microbiol 45: 1183–1187
Tapia MO, Seawright AA (1985) Experimental combined aflatoxin B1 and ochratoxin A intoxication in pigs. Aust Vet J 62: 33–37
Van der Merwe KJ, Steyn PS, Fourrie L, Scott DB, Theron JJ (1965) Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus Wilh. Nature 205: 1112–1113
Van Egmond HP (1991) Worldwide regulations for ochratoxin A. In: Castegnaro M, Plestina R, Dirheimer G, Chernozemsky IN, Bartsch H (eds) Mycotoxin, Endemic Nephropathy and urinary tract tumours, vol 115. IARC Scientific Publications, Lyon, pp 331–336
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maaroufi, K., Achour, A., Betbeder, A.M. et al. Foodstuffs and human blood contamination by the mycotoxin ochratoxin A: correlation with chronic interstitial nephropathy in Tunisia. Arch Toxicol 69, 552–558 (1995). https://doi.org/10.1007/s002040050211
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s002040050211